23andme

23andMe Ramps Up Its Focus on Parkinson's Disease With Help from Google Co-Founder

23andMe, a Silicon Valley- based personal genomics company, made headlines March 12 when it announced a project to enroll up to 10,000 people with Parkinson's to advance research into the disease's causes. The initiative is being funded by Google co-founder Sergey Brin, who  has a genetic mutation that is linked to the disease. Linda Avey, 23andMe's co-founder,  spoke to Informilo recently about why the company  is zeroing in on Parkinson's disease, the evolution of personalized medicine and the firm's international expansion. Click on the video.Read more

Esther Dyson: To Infinity and Beyond

Internet doyenne Esther Dyson was awarded the Aenne Burda Creative Leadership award at the Digital, Live, Design or DLD conference in Munich on January 25.  Dyson,  who is currently training to be a cosmonaut, talked to Informilo about why this is a great time to start a business, her investments in Russia, personalized medicine and space technology.Read more

Syndicate content